BREAKING NEWS
This content is not available in your region

Consort Medical agrees to 505 million pound buyout by Sweden's Recipharm

Text size Aa Aa

(Reuters) – Consort Medical Plc <CSRT.L> on Monday said Sweden’s Recipharm AB <RECIb.ST> would buy the London-listed healthcare company for 1,010 pence per share in cash.

Consort said the offer represented a premium of 39.1% to Friday’s close of 726 pence, valuing the company at about 505 million pounds ($646.20 million) on a fully diluted basis.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Subhranshu Sahu)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.